welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Specific Hypomethylated CPGS at the IGF2 Locus Act as an Epigenetic Biomarker for Familial Adenomatous Polyposis Colorectal Cancer
source: Epigenomics
year: 2010
authors: Miroglio A, Jammes H, Tost J, Ponger L, Gut I G, El Abdalaoui H, Coste J, Chaussade S, Arimondo P B, Lamarque D, Dandolo L
summary/abstract:AIMS : The identification of specific biomarkers for colorectal cancer is of primary importance for early diagnosis. The aim of this study was to evaluate if methylation changes at the IGF2/H19 locus could be predictive for individuals at high risk for developing sporadic or hereditary colorectal cancer.
MATERIALS & METHODS : Quantitative methylation analysis using pyrosequencing was performed on three differentially methylated regions (DMRs): IGF2 DMR0 and DMR2 and the H19 DMR in DNA samples from sporadic colorectal cancer (n = 26), familial adenomatous polyposis (n = 35) and hereditary nonpolyposis colorectal cancer (n = 19) patients.
RESULTS : We report in this article for the first time, that in sporadic colorectal cancer tumor DNA both the IGF2 DMR0 and DMR2 are hypomethylated, while the H19 DMR retains its monoallelic methylation pattern. In lymphocyte DNA, a striking hypomethylation of nine contiguous correlated CpGs was found in the IGF2 DMR2 but only in familial adenomatous polyposis patients.
CONCLUSION : Methylation alterations at the IGF2 locus are more extensive than previously reported and DMR2 hypomethylation in lymphocyte DNA might be a specific epigenetic biomarker for familial adenomatous polyposis patients.
organization: University Paris DescartesDOI: 10.2217/epi.10.24
read more full text source
expertly curated content related to this topic
-
Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
-
How to Manage a Patient with Multiple Adenomatous Polyps: History and Clinical Features, Genetic Testing, Surveillan...Adenomatous polyps are found on screenin...
-
Familial Risk-Colorectal Cancer: ESMO Clinical Practice GuidelinesLynch syndrome is the most common heredi...
-
Education and Management of Patients with Familial Adenomatous Polyposis. Are We Making Progress? A Case ReportAbstract: A 25-year-old male patient was...
-
New Research Verifies TASINs as Viable Target for Colon Cancer TherapiesA small molecule called TASIN-1 can sele...
-
How to Defy a Hereditary Predisposition and Prevent Colon Cancerhttps://www.youtube.com/watch?v=IynYbT2i...
-
Colorectal Carcinomas, A Consideration on MutYH-Associated PolyposisColorectal cancer (CRC) is the second mo...